The Texas Alzheimer’s Research and Care Consortium (TARCC) Steering Committee (SC) was established to advise the Council on consortium matters, as defined in Chapter 154, Consortium of Alzheimer’s Disease Centers, Section 154.004, Texas Education Code. Each participating TARCC institution has one Steering Committee member as appointed by their respective institution and approved by the Council.
Each SC member provides expertise, input and guidance on the following key issues through regular conference calls and annual meetings:
- TARCC scientific direction and growth
- Enhancing awareness of TARCC activities
- Dissemination of information about collaborative projects and grant opportunities
- Fostering collaborative TARCC data-use projects
- Monitoring progress of each site's TARCC grants
- Reviewing TARCC data access requests
- Reviewing abstracts and proposals for TARCC conferences
- Participation in biannual review sessions
The Steering Committee, acting through the Scientific Director, Dr. Munro Cullum at UT Southwestern, advises the Council on consortium activities, including the setting of research priorities and policies, appropriate use of resources, project progress, and reporting of findings among the participating medical schools and health science centers.
Baylor College of Medicine, Houston
Valory Pavlik, Ph.D., is an associate professor in the Department of Neurology and the Department of Family and Community Medicine at Baylor College of Medicine. She received her Ph.D. in Epidemiology from the University of Texas School of Public Health in Houston, Texas in 1994.
Primary Research Interests: Risk factors for cognitive decline and AD with a focus on cardiovascular risk factors, racial/ethnic group differences in risk of MCI and AD, predictors of progression in MCI and AD. Dr. Pavlik is also active in the management of AD treatment and prevention trials carried out in the Alzheimer’s Disease and Memory Disorders Center at Baylor College of Medicine.
Texas A & M Health Science Center, Bryan
Marcia G. Ory, Ph.D., MPH, is a Regents and Distinguished Professor at the Texas A&M School of Public Health and also serves as associate vice president of strategic partnerships and initiatives for the Health Sciences Center. In these roles, Dr. Ory identifies and evaluates health promotion and chronic disease self-management programs with the goal of improving population health. As co-director of Healthy South Texas and Center for Population Health and Aging, Dr. Ory has built successful models of health initiatives that have expanded across the state, making a positive difference in the lives of Texans Dr. Ory received a PhD from Purdue University in Human Development and Family Studies and a MPH from the Johns Hopkins university in behavioral sciences and epidemiology.
Primary Research Interests: Social and behavioral aspects of Alzheimer’s disease and related disorders; Evidence based interventions for older adults and their caregiver; Linkages between community and clinical care.
Texas Tech University Health Sciences Center, Lubbock
Parunyou Julayanont, M.D., is a Behavioral Neurologist, Corinne Payne Wright Regent Endowed Chair in Alzheimer's Disease, Director of Behavioral and Cognitive Neurology Clinic, and Assistant Professor of the Department of Neurology at Texas Tech University Health Sciences Center, Lubbock. Dr. Julayanont received his medical degree from Chulalongkorn University, Bangkok, Thailand in 2011. After graduation from the residency training in Neurology at Texas Tech University Health Sciences Center, Lubbock, he further advanced his clinical fellowship training in Behavioral Neurology and Neuropsychiatry at the University of Florida, College of Medicine, Gainesville, FL. He is board certified in Behavioral Neurology and Neuropsychiatry.
Primary Research Interests: Primary investigator of the Longitudinal Continuation of TARCC Hispanic Cohort at TTUHSC; Behavioral Neurology and Neuropsychiatry in dementias and movement disorders.
The University of Texas at Austin, Dell Medical School
David Paydarfar, M.D., is Professor and inaugural Chair of the Department of Neurology at UT Austin Dell Medical School. He received his M.D. from the University of North Carolina at Chapel Hill in 1985. He is a leading innovator with a unique background in physics and neurology.
Primary Research Interests: Developing biosensors, signal-processing algorithms, and user interfaces to inform predictive health analytics. Studying the underlying disease states associated with abnormal behavior of neural oscillators such as sleep apnea, circadian dysrhythmias, and epilepsy.
The University of Texas Health Sciences Center at San Antonio
Donald R. Royall, M.D., is Chief of the Division of Aging and Geriatric Psychiatry, the Julia and Vann Buren Parr Professor of Geriatric Psychiatry, and a professor in the departments of Medicine and Family & Community Medicine at The University of Texas Health Science Center at San Antonio. Dr. Royall received his medical degree from The University of Texas Health Science Center at Houston and completed residency training in both Internal Medicine and Psychiatry at the Johns Hopkins Hospital in Baltimore, MD.
Primary Research Interests: Dementia and its essential cognitive and behavioral features as manifested in Aging, Alzheimer’s disease (AD), depression, Lewy Body disease (LBD), and Vascular Dementia (VaD).
UT Southwestern Medical Center, Dallas
Munro Cullum, Ph.D., is Professor of Psychiatry, Neurology and Neurotherapeutics, and Neurological Surgery at The University of Texas Southwestern Medical Center. He holds the Pam Blumenthal Distinguished Professorship in Clinical Psychology, is Chief of Psychology and the senior neuropsychologist in the O’Donnell Brain Institute. He also serves as the chair of the TARCC External Advisory Committee Compliance Committee. Dr. Cullum received his Ph.D. in Clinical Psychology from the University of Texas at Austin and is a Past-President of the Society for Clinical Neuropsychology (APA Divisoin 40) and the National Academy of Neuropsychology.
Primary Research Interests: Neuropsychological aspects of neurodegenerative disorders, including early detection, differential diagnosis, and progression; detection, recovery, and late effects of brain injury; neuropsychological assessment.
University of North Texas Health Science Center, Fort Worth
Robert C. Barber, Ph.D., is an associate professor in the Department of Pharmacology & Neuroscience and Director of the Genetics Core in the Institute for Translational Research at the University of North Texas Health Science Center in Fort Worth. He received his PhD in Genetics from Texas A&M University in 1997.
Primary Research Interests: Genetic and epigenetic biomarkers and risk factors for neurodegeneration as well as the influence of ethnicity on disease risk and progression. Ongoing projects include efforts to identify patterns of differential DNA methylation that predict the risk and age at onset of Alzheimer’s disease among Mexican Americans and non-Hispanic whites.
University of Texas Medical Branch, Galveston
Kelly Dineley, Ph.D., joined the faculty ranks at the University of Texas Medical Branch (UTMB) in 2003. She has steadily funded her research with grants from the National Institutes of Health, the John Sealy Memorial Endowment Fund for Biomedical Research, the Dunn Foundation, the Brown Foundation, Inc., the Alzheimer’s Association, the Bright Focus Foundation, the Peter F. McManus Foundation, and the Mohn Foundation. She received her PhD in Neuroscience in 1998 from Baylor College of Medicine in Houston, Texas.
Primary Research Interests:
Alzheimer’s disease, Parkinson’s disease, and related proteinopathies - amyloidopathies, tauopathies, synucleinopathies; Cocaine abuse and addiction neurocircuitry; Neuroinflammation and neuro-infectious disease; Animal models utilizing genetic and pharmacological manipulations; Omics and bioinformatics approaches for the identification and validation of novel mechanisms and interventions; and Nicotinic acetylcholine receptors, nuclear receptors (PPAR), ERK MAPK, CREB, CBP, calcineurin, protein-protein interactions
The University of Texas Health Science Center, Houston
Rodrigo Morales, Ph.D., is an Associate Professor of the Department of Neurology. Dr. Morales obtained his BSc degree (biochemistry) from Universidad de Chile. His Ph.D., also from Universidad de Chile, included all thesis work done at The University of Texas Medical Branch at Galveston. He joined UTHealth in 2009 as a post-doctoral fellow and was appointed as an Assistant Professor in 2012.
Primary Research Interests:
Dr. Morales main research topics involve the strain and species barrier phenomena in prion diseases, the prion-like nature of Aβ aggregates in Alzheimer’s disease and the pathological interaction between these disorders.
The University of Texas Rio Grande Valley School of Medicine
Michael R. Dobbs, MD, MHCM, is Vice Dean for Clinical Affairs and Professor/Chair of Neurology at University of Texas Rio Grande Valley. He holds advanced degrees from the University of Kentucky and Harvard. He served with distinction in the US Air Force Medical Corps including an academic appointment at the Uniformed Services University of Health Sciences. He has authored more than 50 publications including books, book chapters, journal articles, and abstracts. His book Clinical Neurotoxicology—Syndromes, Substances, Environments is a leading text in the field worldwide. As Vice Dean, Dobbs shares oversight of UT Health RGV which is rapidly growing to provide academic medical care to a previously underserved region. As chair of neurology, he is simultaneously building a department that provides advanced neurology care, education, and research.
Primary Research Interests:
He has been institutional principal investigator on multiple clinical trials and has published original research in stroke outcomes. At the University of Kentucky, he led his hospital to become one of the busiest stroke centers in the United States while also building a 34 hospital Stroke Network that continues to grow and bring life-saving treatments to underserved regions in Appalachia. He also led a team that created a novel data management system, the “Kentucky-Appalachian Stroke Registry”, which has fueled clinical trials and original publications.